(Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Turnover | 54.49%1.82B | 54.73%1.13B | 43.03%493.44M | 31.24%1.82B | 26.95%1.18B | 31.39%727.95M | 32.37%345M | 17.70%1.39B | 7.00%926.74M | -3.31%554.05M |
Operating income | 54.49%1.82B | 54.73%1.13B | 43.03%493.44M | 31.24%1.82B | 26.95%1.18B | 31.39%727.95M | 32.37%345M | 17.70%1.39B | 7.00%926.74M | -3.31%554.05M |
Operating expenses | -53.26%-1.46B | -53.37%-903.55M | -46.71%-391.33M | -29.25%-1.44B | -25.69%-952.31M | -29.76%-589.14M | -22.17%-266.73M | -20.86%-1.12B | -14.16%-757.68M | -5.07%-454.02M |
Gross profit | 59.70%358.08M | 60.52%222.81M | 30.46%102.11M | 39.47%375.18M | 32.62%224.21M | 38.76%138.8M | 85.03%78.27M | 6.17%269M | -16.47%169.06M | -28.99%100.03M |
Selling expenses | -25.14%-35.24M | -22.31%-21.98M | -63.82%-19.24M | -21.34%-63.15M | 19.76%-28.16M | 19.01%-17.97M | -17.73%-11.74M | 5.40%-52.04M | 34.93%-35.09M | 39.85%-22.19M |
Administrative expenses | -28.81%-93.98M | -35.20%-61.92M | -25.19%-29.05M | -24.46%-109.31M | -22.30%-72.96M | -23.22%-45.8M | -35.03%-23.2M | -5.67%-87.82M | -0.79%-59.65M | 6.89%-37.17M |
Research and development expenses | -26.84%-100.6M | -28.21%-64.48M | -1.97%-25.78M | -18.59%-118.2M | -20.85%-79.31M | -23.32%-50.29M | -24.38%-25.28M | -23.84%-99.67M | -15.04%-65.63M | -9.02%-40.78M |
Profit from asset sales | -49.85%-1.52M | -31.45%-1.29M | 52.84%-290.66K | -109.26%-473.68K | -119.60%-1.01M | -118.97%-984.17K | -112.03%-616.29K | 453.35%5.11M | -10.32%5.17M | -6.16%5.19M |
Revaluation surplus | 417.82%509.69K | 64.16%-132.92K | -389.08%-364.63K | 76.73%-265.7K | 73.77%-160.37K | 63.89%-370.86K | 96.85%-74.55K | -186.37%-1.14M | -144.23%-611.42K | -1,095.12%-1.03M |
-Changes in the fair value of other assets | 417.82%509.69K | 64.16%-132.92K | -389.08%-364.63K | 76.73%-265.7K | 73.77%-160.37K | 63.89%-370.86K | 96.85%-74.55K | -186.37%-1.14M | -144.23%-611.42K | -1,095.12%-1.03M |
Impairment and provision | -418.75%-18.53M | -96.71%-8.25M | 16.55%-5.97M | 52.98%-10.14M | 71.45%-3.57M | 45.85%-4.19M | -61.08%-7.16M | -41.66%-21.56M | -252.10%-12.51M | -116.19%-7.75M |
-Other impairment is provision | -418.75%-18.53M | -96.71%-8.25M | 16.55%-5.97M | 52.98%-10.14M | 71.45%-3.57M | 45.85%-4.19M | -61.08%-7.16M | -41.66%-21.56M | -252.10%-12.51M | -116.19%-7.75M |
Special items of operating profit | 60.06%24.8M | 62.11%16.24M | 131.56%8.01M | 52.88%31.78M | -4.54%15.5M | -8.90%10.02M | -36.31%3.46M | -19.07%20.79M | 8.85%16.23M | 1.76%11M |
Operating profit | 167.53%122.69M | 212.28%74.38M | 137.98%26.54M | 294.95%92.71M | 348.12%45.86M | 611.47%23.82M | 400.19%11.15M | -27.67%23.47M | -77.23%10.23M | -90.66%3.35M |
Financing cost | 76.92%-1.08M | 79.96%-612.67K | -25.51%-1.87M | -25.16%-6.07M | -30.01%-4.69M | -12.14%-3.06M | -12.16%-1.49M | -1.05%-4.85M | 11.06%-3.61M | -26.45%-2.73M |
Special items of earning before tax | -54.84%-1.06M | -135.21%-754.07K | 345.21%181.29K | -23,376.13%-2.63M | -644.48%-682.46K | -259.32%-320.59K | -65.06%-73.93K | -75.28%11.31K | 27,882.03%125.34K | -700.95%-89.22K |
Earning before tax | 197.76%120.55M | 257.19%73.02M | 159.12%24.86M | 350.83%84M | 499.76%40.49M | 3,736.74%20.44M | 288.64%9.59M | -32.73%18.63M | -83.49%6.75M | -98.42%532.79K |
Tax | 244.47%6.79M | 293.68%3.09M | 109.22%716.45K | 333.60%862.49K | 68.00%1.97M | 9.40%784K | -22.54%342.43K | 82.44%-369.21K | 155.93%1.17M | 159.92%716.61K |
After-tax profit from continuing operations | 199.93%127.34M | 258.54%76.1M | 157.41%25.58M | 364.67%84.87M | 435.80%42.46M | 1,598.87%21.23M | 313.97%9.94M | -28.64%18.26M | -79.57%7.92M | -96.16%1.25M |
Earning after tax | 199.93%127.34M | 258.54%76.1M | 157.41%25.58M | 364.67%84.87M | 435.80%42.46M | 1,598.87%21.23M | 313.97%9.94M | -28.64%18.26M | -79.57%7.92M | -96.16%1.25M |
Minority profit | 787.38%15.36M | 563.65%9.21M | 338.45%3.8M | 213.96%7.66M | 6.62%1.73M | 252.63%1.39M | 241.66%865.95K | 128.50%2.44M | 144.91%1.62M | 120.46%393.76K |
Profit attributable to shareholders | 174.96%111.98M | 237.18%66.89M | 140.12%21.78M | 387.91%77.2M | 546.38%40.73M | 2,218.41%19.84M | 324.93%9.07M | -53.67%15.82M | -85.14%6.3M | -97.52%855.64K |
Basic earnings per share | 167.44%0.138 | 230.68%0.083 | 140.00%0.0276 | 400.00%0.1 | 545.00%0.0516 | 2,181.82%0.0251 | 325.49%0.0115 | -50.00%0.02 | -85.10%0.008 | -97.48%0.0011 |
Diluted earnings per share | 167.44%0.138 | 230.68%0.083 | 140.00%0.0276 | 400.00%0.1 | 545.00%0.0516 | 2,181.82%0.0251 | 325.49%0.0115 | -50.00%0.02 | -85.10%0.008 | -97.48%0.0011 |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- | -- |
Auditor | -- | -- | -- | Tianjian Certified Public Accountants (Special General Partnership) | -- | -- | -- | Tianjian Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data